Davide Scalvini

ORCID: 0009-0002-7051-5432
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Microscopic Colitis
  • Inflammatory Bowel Disease
  • Celiac Disease Research and Management
  • Biliary and Gastrointestinal Fistulas
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Surgical Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Congenital Anomalies and Fetal Surgery
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Digestive system and related health
  • Helicobacter pylori-related gastroenterology studies
  • Whipple's Disease and Interleukins
  • Appendicitis Diagnosis and Management
  • Liver Disease Diagnosis and Treatment
  • IL-33, ST2, and ILC Pathways
  • Nutrition and Health in Aging
  • Pancreatitis Pathology and Treatment
  • Organ Transplantation Techniques and Outcomes
  • Pharmacology and Obesity Treatment
  • Gastrointestinal Bleeding Diagnosis and Treatment

University of Pavia
2021-2025

Policlinico San Matteo Fondazione
2023-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2023-2025

Istituti Clinici Scientifici Maugeri
2021-2025

Aziende Socio Sanitaria Territoriale Rhodense
2023-2024

CTO Hospital
2024

Patients presenting with acute colonic obstruction are usually evaluated in the emergency department and multiple specialties involved patients’ management. Pre-treatment evaluation is essential order to establish correct endoscopic indication for stent implantation. Contrast-enhanced imaging could allow exclusion of benign causes length malignant stricture. Endoscopic stenting gold standard treatment palliative indications whereas there still concerns about its use as a bridge surgery....

10.3390/cancers16040821 article EN Cancers 2024-02-18

Ongoing symptoms in treated celiac disease (CD) are frequent and commonly thought of as being due to infractions a gluten-free diet (GFD) or complications. To study the etiology natural history clinically relevant events (CREs) throughout follow-up identify predictors thereof guide follow-up. CREs (symptoms/signs requiring diagnostic/therapeutic interventions) occurring patients between January-2000 May-2021 were retrospectively collected June September 2021 analysed....

10.1007/s10620-022-07727-x article EN cc-by-nc Digestive Diseases and Sciences 2022-11-18

(1) Background: GP2017 is one of the biosimilar drugs adalimumab, anti-TNF agents used for inflammatory bowel disease (IBD). To date, there little real-world data about use in IBD patients. The aim our study was to evaluate effectiveness and safety this an population. (2) Methods: This observational retrospective including patients that were all treated with as a first step or switch from originator other biosimilars. clinical activity evaluated at baseline after 6 12 months therapy. therapy...

10.3390/jcm12216839 article EN Journal of Clinical Medicine 2023-10-29

INTRODUCTION: Long-term prognosis of non-celiac enteropathies (NCEs) is poorly understood. We aimed to evaluate long-term outcomes and develop a prognostic score for NCEs. METHODS: NCEs patients from an international multicenter cohort (4 Italian centers,1 UK, 1 French,1 Norwegian,1 USA,1 Indian) followed-up over 30 years were enrolled. Complications mortality analysed with Kaplan-Meier curves, standardized ratios (SMR) multivariate Cox regression. A clinical identify at risk poor was...

10.14309/ajg.0000000000003331 article EN cc-by-nc-nd The American Journal of Gastroenterology 2025-01-29
Coming Soon ...